← Back to Search

STEP-YA for Sleep Disorders in Cancer Survivors

N/A
Recruiting
Led By Christopher J Recklitis, PhD, MPH
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No active cancer therapy (excluding chemoprevention) in the past four months, and no further therapy planned
Age 20-39
Must not have
Survivors who report being diagnosed with sleep apnea who are not receiving recommended medical treatment for their sleep apnea
Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks post-intervention session
Awards & highlights
No Placebo-Only Group

Summary

This trial is exploring if an online education session on sleep, with or without coaching, can help improve the sleep of young adult cancer survivors. The name of the study is Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA).

Who is the study for?
This trial is for young adult cancer survivors aged 20-39 who have been cancer-free and off active therapy for at least four months. They must be experiencing significant insomnia, able to read/write in English, and diagnosed with cancer over a year ago. Exclusions include bipolar or seizure disorders, untreated sleep apnea, irregular sleep patterns due to work, recent insomnia treatments, or plans to change medications affecting sleep.
What is being tested?
The STEP-YA program aims to improve the sleep of young adult cancer survivors through an online education session. The study compares the effectiveness of this session alone versus the session combined with individualized coaching sessions.
What are the potential side effects?
As STEP-YA involves educational content and possibly coaching sessions without medication or invasive procedures, no direct side effects are expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I haven't had cancer treatment in the last 4 months and don't plan to have more.
Select...
I am between 20 and 39 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have sleep apnea but am not getting treatment for it.
Select...
I do not have any impairments that prevent me from completing study tasks on my own.
Select...
I have been diagnosed with a seizure disorder or had a seizure in the last year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks post-intervention session
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks post-intervention session for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Insomnia Severity Change at 8 Weeks
Secondary study objectives
Insomnia Severity Change at 4 weeks
Profile of Mood States Change at 4 weeks
Profile of Mood States Change at 8 weeks
Other study objectives
Final satisfaction with the intervention
Initial Satisfaction with Intervention Session
Insomnia Severity at 16 weeks (optional)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: COACHING CONDITION STEP-YAExperimental Treatment1 Intervention
Participants will receive a single online education session and complete online questionnaire then be randomized to receive 2 individualized remote coaching sessions. Participates will also complete follow up questionaires at 4 and 8 weeks post baseline.
Group II: NON-COACHING CONDITION STEP-YAActive Control1 Intervention
Participants will receive a single online education session and complete online questionnaires then be randomized to not receive additional coaching support sessions. Participates will also complete follow up questionaires at 4 and 8 weeks post baseline.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,108 Previous Clinical Trials
357,163 Total Patients Enrolled
6 Trials studying Insomnia
490 Patients Enrolled for Insomnia
National Cancer Institute (NCI)NIH
13,917 Previous Clinical Trials
41,014,393 Total Patients Enrolled
10 Trials studying Insomnia
1,921 Patients Enrolled for Insomnia
Christopher J Recklitis, PhD, MPHPrincipal InvestigatorDana-Farber Cancer Institute

Media Library

STEP-YA with Coaching Clinical Trial Eligibility Overview. Trial Name: NCT05358951 — N/A
Insomnia Research Study Groups: NON-COACHING CONDITION STEP-YA, COACHING CONDITION STEP-YA
Insomnia Clinical Trial 2023: STEP-YA with Coaching Highlights & Side Effects. Trial Name: NCT05358951 — N/A
STEP-YA with Coaching 2023 Treatment Timeline for Medical Study. Trial Name: NCT05358951 — N/A
~13 spots leftby Apr 2025